{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:28:49Z","timestamp":1792024129565,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-021165"],"award-info":[{"award-number":["MJFF-021165"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-021165"],"award-info":[{"award-number":["MJFF-021165"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-021165"],"award-info":[{"award-number":["MJFF-021165"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-00963-8","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:06:09Z","timestamp":1745582769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["IC100 blocks inflammasome activation induced by \u03b1-synuclein aggregates and ASC specks"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2924-7416","authenticated-orcid":false,"given":"Brianna","family":"Cyr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina T.","family":"Vontell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roey","family":"Hadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"de Rivero Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"963_CR1","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3233\/JPD-223338","volume":"12","author":"S Jewell","year":"2022","unstructured":"Jewell, S., Herath, A. M. & Gordon, R. Inflammasome activation in Parkinson\u2019s disease. J. Parkinsons Dis. 12, S113\u2013S128 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"963_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka, M. T., McManus, R. M. & Latz, E. Inflammasome signalling in brain function and neurodegenerative disease. Nat. Rev. Neurosci. 19, 610\u2013621 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"963_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka, M. T. et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493, 674\u2013678 (2013).","journal-title":"Nature"},{"key":"963_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"963_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam, N. et al. Dynamic physiological alpha-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Parkinsons Dis. 9, 4 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"963_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems, J. et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol. 141, 159\u2013172 (2021).","journal-title":"Acta Neuropathol."},{"key":"963_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi, K. et al. The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol. Neurobiol. 47, 495\u2013508 (2013).","journal-title":"Mol. Neurobiol."},{"key":"963_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature 575, 669\u2013673 (2019).","journal-title":"Nature"},{"key":"963_CR9","doi-asserted-by":"publisher","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","volume":"10","author":"R Gordon","year":"2018","unstructured":"Gordon, R. et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 10, eaah4066 (2018).","journal-title":"Sci. Transl. Med."},{"key":"963_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","volume":"4","author":"KM von Herrmann","year":"2018","unstructured":"von Herrmann, K. M. et al. NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson\u2019s disease. NPJ Parkinsons Dis. 4, 24 (2018).","journal-title":"NPJ Parkinsons Dis."},{"key":"963_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-020-00147-6","volume":"7","author":"FL Anderson","year":"2021","unstructured":"Anderson, F. L. et al. Plasma-borne indicators of inflammasome activity in Parkinson\u2019s disease patients. NPJ Parkinsons Dis. 7, 2 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"963_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577089","volume":"338","author":"K Chatterjee","year":"2020","unstructured":"Chatterjee, K. et al. Inflammasome and alpha-synuclein in Parkinson\u2019s disease: a cross-sectional study. J. Neuroimmunol. 338, 577089 (2020).","journal-title":"J. Neuroimmunol."},{"key":"963_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/ph16060883","volume":"16","author":"E Cabrera Ranaldi","year":"2023","unstructured":"Cabrera Ranaldi, E. et al. Proof-of-principle study of inflammasome signaling proteins as diagnostic biomarkers of the inflammatory response in Parkinson\u2019s disease. Pharmaceuticals 16, 883 (2023).","journal-title":"Pharmaceuticals"},{"key":"963_CR14","first-page":"931","volume":"19","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. alpha-synuclein promotes progression of Parkinson\u2019s disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome. Exp. Ther. Med. 19, 931\u2013938 (2020).","journal-title":"Exp. Ther. Med."},{"key":"963_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11929","volume":"7","author":"MS Dick","year":"2016","unstructured":"Dick, M. S., Sborgi, L., Ruhl, S., Hiller, S. & Broz, P. ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat. Commun. 7, 11929 (2016).","journal-title":"Nat. Commun."},{"key":"963_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","volume":"15","author":"BS Franklin","year":"2014","unstructured":"Franklin, B. S. et al. The adaptor ASC has extracellular and \u2018prionoid\u2019 activities that propagate inflammation. Nat. Immunol. 15, 727\u2013737 (2014).","journal-title":"Nat. Immunol."},{"key":"963_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi, I. et al. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat. Commun. 11, 1386 (2020).","journal-title":"Nat. Commun."},{"key":"963_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang, W. et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J. 19, 533\u2013542 (2005).","journal-title":"FASEB J."},{"key":"963_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-22","volume":"9","author":"SS Minami","year":"2012","unstructured":"Minami, S. S. et al. Selective targeting of microglia by quantum dots. J. Neuroinflamm. 9, 22 (2012).","journal-title":"J. Neuroinflamm."},{"key":"963_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-04780-4","volume":"12","author":"S Awa","year":"2022","unstructured":"Awa, S. et al. Phosphorylation of endogenous alpha-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body. Sci. Rep. 12, 1163 (2022).","journal-title":"Sci. Rep."},{"key":"963_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/glia.24626","volume":"73","author":"J Niskanen","year":"2024","unstructured":"Niskanen, J. et al. Uptake of alpha-synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia. Glia. 73, 159\u2013174 (2024).","journal-title":"Glia."},{"key":"963_CR22","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich, H. et al. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell 184, 5089\u20135106.e5021 (2021).","journal-title":"Cell"},{"key":"963_CR23","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.3233\/JPD-223237","volume":"12","author":"N Stefanova","year":"2022","unstructured":"Stefanova, N. Microglia in Parkinson\u2019s disease. J. Parkinsons Dis. 12, S105\u2013S112 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"963_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577543","volume":"354","author":"S Huang","year":"2021","unstructured":"Huang, S. et al. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease. J. Neuroimmunol. 354, 577543 (2021).","journal-title":"J. Neuroimmunol."},{"key":"963_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2021.05.008","volume":"349","author":"X Qiu","year":"2021","unstructured":"Qiu, X. et al. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson\u2019s disease model. Toxicol. Lett. 349, 1\u201311 (2021).","journal-title":"Toxicol. Lett."},{"key":"963_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15314-8","volume":"7","author":"DW Shim","year":"2017","unstructured":"Shim, D. W. et al. BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination. Sci. Rep. 7, 15020 (2017).","journal-title":"Sci. Rep."},{"key":"963_CR27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ni.2919","volume":"15","author":"A Baroja-Mazo","year":"2014","unstructured":"Baroja-Mazo, A. et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15, 738\u2013748 (2014).","journal-title":"Nat. Immunol."},{"key":"963_CR28","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann, N. et al. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 117, 32145\u201332154 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"963_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.trsl.2022.06.016","volume":"251","author":"JP de Rivero Vaccari","year":"2023","unstructured":"de Rivero Vaccari, J. P. et al. Mechanism of action of IC 100, a humanized IgG4 monoclonal antibody targeting apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). Transl. Res. 251, 27\u201340 (2023).","journal-title":"Transl. Res."},{"key":"963_CR30","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1523\/JNEUROSCI.0157-08.2008","volume":"28","author":"JP de Rivero Vaccari","year":"2008","unstructured":"de Rivero Vaccari, J. P., Lotocki, G., Marcillo, A. E., Dietrich, W. D. & Keane, R. W. A molecular platform in neurons regulates inflammation after spinal cord injury. J. Neurosci. 28, 3404\u20133414 (2008).","journal-title":"J. Neurosci."},{"key":"963_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2022.08.014","volume":"254","author":"NH Johnson","year":"2023","unstructured":"Johnson, N. H., de Rivero Vaccari, J. P., Bramlett, H. M., Keane, R. W. & Dietrich, W. D. Inflammasome activation in traumatic brain injury and Alzheimer\u2019s disease. Transl. Res. 254, 1\u201312 (2023).","journal-title":"Transl. Res."},{"key":"963_CR32","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1089\/neu.2017.5430","volume":"35","author":"NA Kerr","year":"2018","unstructured":"Kerr, N. A. et al. Traumatic brain injury-induced acute lung injury: evidence for activation and inhibition of a neural-respiratory-inflammasome axis. J. Neurotrauma 35, 2067\u20132076 (2018).","journal-title":"J. Neurotrauma"},{"key":"963_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01826-0","volume":"17","author":"HL Desu","year":"2020","unstructured":"Desu, H. L. et al. IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis. J. Neuroinflamm. 17, 143 (2020).","journal-title":"J. Neuroinflamm."},{"key":"963_CR34","doi-asserted-by":"publisher","first-page":"774014","DOI":"10.3389\/fnmol.2022.774014","volume":"15","author":"B Cyr","year":"2022","unstructured":"Cyr, B., Hadad, R., Keane, R. W. & de Rivero Vaccari, J. P. The Role of Non-canonical and Canonical Inflammasomes in Inflammaging. Front. Mol. Neurosci. 15, 774014 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"963_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13142","volume":"33","author":"RT Vontell","year":"2023","unstructured":"Vontell, R. T. et al. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer\u2019s disease. Brain Pathol. 33, e13142 (2023).","journal-title":"Brain Pathol."},{"key":"963_CR36","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1073\/pnas.1610099113","volume":"113","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein alpha-synuclein. Proc. Natl Acad. Sci. USA 113, 9587\u20139592 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"963_CR37","doi-asserted-by":"publisher","first-page":"805169","DOI":"10.3389\/fnmol.2022.805169","volume":"15","author":"J Hulse","year":"2022","unstructured":"Hulse, J. & Bhaskar, K. Crosstalk between the NLRP3 inflammasome\/ASC speck and amyloid protein aggregates drives disease progression in Alzheimer\u2019s and Parkinson\u2019s disease. Front. Mol. Neurosci. 15, 805169 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"963_CR38","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo, G. et al. Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8, e55375 (2013).","journal-title":"PLoS ONE"},{"key":"963_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","volume":"81","author":"A Kouli","year":"2019","unstructured":"Kouli, A., Horne, C. B. & Williams-Gray, C. H. Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and alpha-synucleinopathies. Brain Behav. Immun. 81, 41\u201351 (2019).","journal-title":"Brain Behav. Immun."},{"key":"963_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02709-w","volume":"20","author":"R Zheng","year":"2023","unstructured":"Zheng, R. et al. ASC specks exacerbate alpha\u2011synuclein pathology via amplifying NLRP3 inflammasome activities. J. Neuroinflamm. 20, 26 (2023).","journal-title":"J. Neuroinflamm."},{"key":"963_CR41","unstructured":"Rocha Cabrero, F. & Morrison, E. H. Lewy bodies. In StatPearls (Treasure Island, FL, 2024)."},{"key":"963_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.celrep.2016.06.011","volume":"16","author":"TC Tzeng","year":"2016","unstructured":"Tzeng, T. C. et al. A fluorescent reporter mouse for inflammasome assembly demonstrates an important role for cell-bound and free ASC specks during in vivo infection. Cell Rep. 16, 571\u2013582 (2016).","journal-title":"Cell Rep."},{"key":"963_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108382","volume":"26","author":"IM Gluck","year":"2023","unstructured":"Gluck, I. M. et al. Nanoscale organization of the endogenous ASC speck. iScience 26, 108382 (2023).","journal-title":"iScience"},{"key":"963_CR44","doi-asserted-by":"publisher","first-page":"e0134912","DOI":"10.1371\/journal.pone.0134912","volume":"10","author":"AC Sahillioglu","year":"2015","unstructured":"Sahillioglu, A. C. & Ozoren, N. Artificial loading of ASC specks with cytosolic antigens. PLoS ONE 10, e0134912 (2015).","journal-title":"PLoS ONE"},{"key":"963_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/jnc.15848","volume":"166","author":"C Kontaxi","year":"2023","unstructured":"Kontaxi, C., Kim, N. & Cousin, M. A. The phospho-regulated amphiphysin\/endophilin interaction is required for synaptic vesicle endocytosis. J. Neurochem. 166, 248\u2013264 (2023).","journal-title":"J. Neurochem."},{"key":"963_CR46","doi-asserted-by":"publisher","first-page":"aah3374","DOI":"10.1126\/science.aah3374","volume":"353","author":"X Mao","year":"2016","unstructured":"Mao, X. et al. Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 353, aah3374 (2016).","journal-title":"Science"},{"key":"963_CR47","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X. et al. Spread of alpha-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat. Neurosci. 22, 1248\u20131257 (2019).","journal-title":"Nat. Neurosci."},{"key":"963_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61757-x","volume":"10","author":"J Courte","year":"2020","unstructured":"Courte, J. et al. The expression level of alpha-synuclein in different neuronal populations is the primary determinant of its prion-like seeding. Sci. Rep. 10, 4895 (2020).","journal-title":"Sci. Rep."},{"key":"963_CR49","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/bpa.12886","volume":"30","author":"H Niu","year":"2020","unstructured":"Niu, H. et al. IL-1beta\/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum. Brain Pathol. 30, 1102\u20131118 (2020).","journal-title":"Brain Pathol."},{"key":"963_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41531-023-00544-7","volume":"9","author":"JM Taymans","year":"2023","unstructured":"Taymans, J. M. et al. Perspective on the current state of the LRRK2 field. NPJ Parkinsons Dis. 9, 104 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"963_CR51","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1084\/jem.20170014","volume":"214","author":"W Liu","year":"2017","unstructured":"Liu, W. et al. LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection. J. Exp. Med. 214, 3051\u20133066 (2017).","journal-title":"J. Exp. Med."},{"key":"963_CR52","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","volume":"64","author":"X Lin","year":"2009","unstructured":"Lin, X. et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein. Neuron 64, 807\u2013827 (2009).","journal-title":"Neuron"},{"key":"963_CR53","doi-asserted-by":"publisher","first-page":"9289","DOI":"10.1073\/pnas.1403215111","volume":"111","author":"JP Daher","year":"2014","unstructured":"Daher, J. P., Volpicelli-Daley, L. A., Blackburn, J. P., Moehle, M. S. & West, A. B. Abrogation of alpha-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats. Proc. Natl Acad. Sci. USA 111, 9289\u20139294 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"963_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105837","volume":"173","author":"A Oun","year":"2022","unstructured":"Oun, A. et al. The multifaceted role of LRRK2 in Parkinson\u2019s disease: from human iPSC to organoids. Neurobiol. Dis. 173, 105837 (2022).","journal-title":"Neurobiol. Dis."},{"key":"963_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey, C. et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice. Brain Behav. Immun. 61, 306\u2013316 (2017).","journal-title":"Brain Behav. Immun."},{"key":"963_CR56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000346158","volume":"35","author":"R Vontell","year":"2013","unstructured":"Vontell, R. et al. Toll-like receptor 3 expression in glia and neurons alters in response to white matter injury in preterm infants. Dev. Neurosci. 35, 130\u2013139 (2013).","journal-title":"Dev. Neurosci."},{"key":"963_CR57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/NEN.0000000000000172","volume":"74","author":"R Vontell","year":"2015","unstructured":"Vontell, R. et al. Cellular mechanisms of toll-like receptor-3 activation in the thalamus are associated with white matter injury in the developing brain. J. Neuropathol. Exp. Neurol. 74, 273\u2013285 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"963_CR58","doi-asserted-by":"crossref","unstructured":"Cyr, B. & de Rivero Vaccari, J. P. Methods to study inflammasome activation in the central nervous system: immunoblotting and immunohistochemistry. In NLR Proteins: Methods and Protocols (eds. Pelegr\u00edn, P. & Di Virgilio, F.) 223\u2013238 (Springer US, New York, NY, 2023).","DOI":"10.1007\/978-1-0716-3350-2_15"},{"key":"963_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0076-6879(08)01413-4","volume":"442","author":"T Fernandes-Alnemri","year":"2008","unstructured":"Fernandes-Alnemri, T. & Alnemri, E. S. Assembly, purification, and assay of the activity of the ASC pyroptosome. Methods Enzymol. 442, 251\u2013270 (2008).","journal-title":"Methods Enzymol."},{"key":"963_CR60","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat. Immunol. 9, 857\u2013865 (2008).","journal-title":"Nat. Immunol."},{"key":"963_CR61","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. Protein identification and analysis tools on the ExPASy server. In The Proteomics Protocols Handbook (ed. Walker, J. M.) 571\u2013607 (Humana Press, Totowa, NJ, 2005).","DOI":"10.1385\/1-59259-890-0:571"},{"key":"963_CR62","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/cells12101372","volume":"12","author":"B Cyr","year":"2023","unstructured":"Cyr, B. & de Rivero Vaccari, J. P. Sex differences in the inflammatory profile in the brain of young and aged mice. Cells 12, 1372 (2023).","journal-title":"Cells"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00963-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00963-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00963-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T13:03:38Z","timestamp":1745586218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00963-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-00963-8","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.d.R.V. and R.W.K. are co-founders and managing members of InflamaCORE, LLC, and have licensed patents on inflammasome proteins as biomarkers of injury and disease, as well as on targeting inflammasome proteins for therapeutic purposes. J.P.d.R.V. and R.W.K. are Scientific Advisory Board Members of ZyVersa Therapeutics Inc. ZyVersa Therapeutics holds licensed patents on IC100 as a therapy against inflammasome-related diseases.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}